Form 10-K
DEF 14A
Teva Gains 6.4% on Another Opioid Case Settlement - TipRanks.com
US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Neth 10/01/2026 3.150 Bond
Teva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent) Sustainability-Linked Senior Notes and the Increase of the Maximum Tender Amount of its Debt Tender Offer | Business Wire
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock
SEC Subpoena For Teva | The FCPA Blog
US88163VAE92 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Llc Bond
DEF 14A
Teva Investor Relations on the App Store
DEF 14A
Bank of New York Mellon Corp Increases Investment in Teva Pharmaceutical Industries Despite Declining Revenue and FDA Warnings - Best Stocks
TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-Q Quarterly Report Filed 2022-05-03
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
DEF 14A
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
DEF 14A
TEVA - Short Interest - Teva Pharmaceutical Industries Ltd. (NYSE) Stock - Short Squeeze, Borrow Rates
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid | Fierce Pharma
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
Teva won't say whether R&D cuts include layoffs; Cipla inks deal for Iranian plant; | Fierce Pharma
DEF 14A
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock
Teva Pharmaceutical Industries Limited (TEVA) Market Cap (2012-2022) History
